PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Price & Overview
NASDAQ:PAHC • US71742Q1067
The current stock price of PAHC is 50.07 USD. Today PAHC is down by -0.71%. In the past month the price decreased by -3.23%. In the past year, price increased by 135.62%.
PAHC Key Statistics
- Market Cap
- 2.029B
- P/E
- 17.88
- Fwd P/E
- 14.59
- EPS (TTM)
- 2.80
- Dividend Yield
- 0.97%
PAHC Stock Performance
PAHC Stock Chart
PAHC Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PAHC. When comparing the yearly performance of all stocks, PAHC is one of the better performing stocks in the market, outperforming 95.38% of all stocks.
PAHC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PAHC. PAHC has an excellent profitability rating, but there are some minor concerns on its financial health.
PAHC Earnings
On February 4, 2026 PAHC reported an EPS of 0.87 and a revenue of 373.90M. The company beat EPS expectations (27.3% surprise) and beat revenue expectations (3.07% surprise).
PAHC Forecast & Estimates
9 analysts have analysed PAHC and the average price target is 46.24 USD. This implies a price decrease of -7.65% is expected in the next year compared to the current price of 50.07.
For the next year, analysts expect an EPS growth of 47.63% and a revenue growth 16.33% for PAHC
PAHC Groups
Sector & Classification
PAHC Financial Highlights
Over the last trailing twelve months PAHC reported a non-GAAP Earnings per Share(EPS) of 2.8. The EPS increased by 73.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.29% | ||
| ROA | 6.55% | ||
| ROE | 27.71% | ||
| Debt/Equity | 2.14 |
PAHC Ownership
PAHC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.6 | 944.634B | ||
| JNJ | JOHNSON & JOHNSON | 20.86 | 587.317B | ||
| MRK | MERCK & CO. INC. | 22.45 | 289.492B | ||
| PFE | PFIZER INC | 9.14 | 154.439B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.47 | 122.453B | ||
| ZTS | ZOETIS INC | 16.92 | 50.862B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.04 | 26.518B | ||
| VTRS | VIATRIS INC | 5.57 | 16.212B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.29 | 11.768B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.508B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.528B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.81B | ||
| LGND | LIGAND PHARMACEUTICALS | 26.06 | 4.233B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PAHC
Company Profile
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 2,475 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Company Info
IPO: 2014-04-11
PHIBRO ANIMAL HEALTH CORP-A
Glenpointe Centre East, 3Rd Floor, 300 Frank W. Burr Blvd., Suite 21
Teaneck NEW JERSEY 07666 US
CEO: Jack C. Bendheim
Employees: 2475
Phone: 12013297300
PHIBRO ANIMAL HEALTH CORP-A / PAHC FAQ
Can you describe the business of PHIBRO ANIMAL HEALTH CORP-A?
Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 2,475 full-time employees. The company went IPO on 2014-04-11. The company develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. The company markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. The company has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
What is the stock price of PHIBRO ANIMAL HEALTH CORP-A today?
The current stock price of PAHC is 50.07 USD. The price decreased by -0.71% in the last trading session.
What is the dividend status of PHIBRO ANIMAL HEALTH CORP-A?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a dividend yield of 0.97%. The yearly dividend amount is currently 0.48.
How is the ChartMill rating for PHIBRO ANIMAL HEALTH CORP-A?
PAHC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What sector and industry does PHIBRO ANIMAL HEALTH CORP-A belong to?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) operates in the Health Care sector and the Pharmaceuticals industry.
Should I buy PAHC stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PAHC.
Can you provide the market cap for PHIBRO ANIMAL HEALTH CORP-A?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a market capitalization of 2.03B USD. This makes PAHC a Mid Cap stock.